Elan Corp PLC (ELN)

[io_io]

Schedule:

By the way I saw your estimate on the BV board:


AAB001- estimate 15 months enrollment + 18 month duration= 33m
==> Sept 2010 for final data
estimate interim after 9 months = Dec 2009


There is no guidance on enrollment, but I expect it will be far faster than you suggest. Unfortunately there is a limiting-step - the parallel EU trials.

One thing that I believe I know is because the "symptomatic" endopoint is usually measured at 6 months, then I would expect that is when the interim look might be.

Therefore I would expect:


aab001 - NA trials (by Elan)
=> estimate 4 months enrollment + 18 month duration = 22m
=> Oct 2009 for final data (if they open the data-box)
=> estimate interim @ 6 months = Oct 2008 (but awaits EU)


aab001 - EU trials (by Wyeth)
=> estimate start Feb '08
=> estimate 6 months enrollment + 18 month duration = 24m
=> Feb 2010 for final data
=> estimate interim after 6 months = Feb 2009